Informations techniques
Exploitant
Laboratoire PROCTER & GAMBLE PHARMACEUTICALS FRANCE
Présentation
INTRINSA 300 µg/24 h, dispositif transdermique Boîte de 8 - Code CIP : 376 704-4
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
LWCTnsN0t91xaNDW